Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Cadenhead, K. S. Articles by Braff, D. L. Search for Related Content PubMed Citation Articles by Cadenhead, K. S. Articles by Braff, D. L. Neurophysiology Other Personality Disorders Schizophrenia Spectrum Disorders Genetics Cognition

Neurobiological Measures of Schizotypal Personality Disorder: Defining an Inhibitory Endophenotype?

OBJECTIVE: Subjects with schizotypal personality disorder demonstrate deficits in inhibition when assessed on prepulse inhibition, P50 suppression, and antisaccade paradigms. This study determined if distinct subgroups of subjects with schizotypal personality disorder could be identified on the basis of performance on these measures and whether endophenotypes could be defined for future genetic study by using measures of inhibitory function. METHOD: Prepulse inhibition, P50 suppression, and antisaccade paradigms were assessed in 21 subjects with schizotypal personality disorder. RESULTS: Seven subjects with schizotypal personality disorder had deficits on each paradigm; seven had no deficits on any paradigm. P50 and antisaccade deficits were present in five of the same subjects and significantly correlated. CONCLUSIONS: These results suggest that P50 and antisaccade performance reflects a common endophenotype and that prepulse inhibition identifies a separate endophenotype reflecting different neurobiological substrate(s) in subjects with schizotypal personality disorder. This pattern may generalize to schizophrenia spectrum disorder patients.

This article has been cited by other articles:

				L. E. Hong, A. Summerfelt, I. Wonodi, H. Adami, R. W. Buchanan, and G. K. Thaker Independent Domains of Inhibitory Gating in Schizophrenia and the Effect of Stimulus Interval Am J Psychiatry, January 1, 2007; 164(1): 61 - 65. [Abstract] [Full Text] [PDF]

				D. Potter, A. Summerfelt, J. Gold, and R. W. Buchanan Review of Clinical Correlates of P50 Sensory Gating Abnormalities in Patients with Schizophrenia Schizophr Bull, October 1, 2006; 32(4): 692 - 700. [Abstract] [Full Text] [PDF]

				S. Louchart-de la Chapelle, I. Nkam, E. Houy, A. Belmont, J.-F. Menard, A.-C. Roussignol, O. Siwek, M. Mezerai, M. Guillermou, G. Fouldrin, et al. A Concordance Study of Three Electrophysiological Measures in Schizophrenia Am J Psychiatry, March 1, 2005; 162(3): 466 - 474. [Abstract] [Full Text] [PDF]

				B. Oranje, C. C. Gispen-de Wied, H. G. M. Westenberg, C. Kemner, M. N. Verbaten, and R. S. Kahn Increasing Dopaminergic Activity: Effects of L-Dopa and Bromocriptine on Human Sensory Gating J Psychopharmacol, September 1, 2004; 18(3): 388 - 394. [Abstract] [PDF]

				L. J. Siever and K. L. Davis The Pathophysiology of Schizophrenia Disorders: Perspectives From the Spectrum Am J Psychiatry, March 1, 2004; 161(3): 398 - 413. [Abstract] [Full Text] [PDF]

				E. A. Hazlett, J. Levine, M. S. Buchsbaum, J. M. Silverman, A. New, E. M. Sevin, L. A. Maldari, and L. J. Siever Deficient Attentional Modulation of the Startle Response in Patients With Schizotypal Personality Disorder Am J Psychiatry, September 1, 2003; 160(9): 1621 - 1626. [Abstract] [Full Text] [PDF]

				I. I. Gottesman and T. D. Gould The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions Am J Psychiatry, April 1, 2003; 160(4): 636 - 645. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2002 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us